![COVID | Free Full-Text | Real-World Safety and Effectiveness of Remdesivir and Corticosteroids in Hospitalized Patients with COVID-19 COVID | Free Full-Text | Real-World Safety and Effectiveness of Remdesivir and Corticosteroids in Hospitalized Patients with COVID-19](https://pub.mdpi-res.com/covid/covid-03-00015/article_deploy/html/images/covid-03-00015-g001-550.jpg?1676617321)
COVID | Free Full-Text | Real-World Safety and Effectiveness of Remdesivir and Corticosteroids in Hospitalized Patients with COVID-19
![Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19 - The Lancet Infectious Diseases Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19 - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/bada8a97-8f1f-41e1-8593-a549be9db8ac/gr1_lrg.jpg)
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19 - The Lancet Infectious Diseases
![FDA approves use of antiviral drug remdesivir as an outpatient therapy for people with covid-19 - The Washington Post FDA approves use of antiviral drug remdesivir as an outpatient therapy for people with covid-19 - The Washington Post](https://www.washingtonpost.com/resizer/Qumw78-tGkR6_LloKGaPZM_UkLU=/arc-anglerfish-washpost-prod-washpost/public/76G7T4BK6II6XHBBHTCQDUEYD4.jpg)
FDA approves use of antiviral drug remdesivir as an outpatient therapy for people with covid-19 - The Washington Post
![World's top intensive care body advises against remdesivir for sickest COVID patients – EURACTIV.com World's top intensive care body advises against remdesivir for sickest COVID patients – EURACTIV.com](https://www.euractiv.com/wp-content/uploads/sites/2/2020/11/Remdesivir-EU-flag-scaled.jpg)
World's top intensive care body advises against remdesivir for sickest COVID patients – EURACTIV.com
![Studie in „Cochrane“ zeigt: Remdesivir hat offenbar geringe bis keine Auswirkung auf Sterblichkeit von COVID-19-Patienten – AC forscht Studie in „Cochrane“ zeigt: Remdesivir hat offenbar geringe bis keine Auswirkung auf Sterblichkeit von COVID-19-Patienten – AC forscht](https://ac-forscht.de/wp-content/uploads/2021/08/AdobeStock_339993774_%C2%A9-Tobias-Arhelger.jpg)
Studie in „Cochrane“ zeigt: Remdesivir hat offenbar geringe bis keine Auswirkung auf Sterblichkeit von COVID-19-Patienten – AC forscht
![Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial - The Lancet Infectious Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial - The Lancet Infectious](https://www.thelancet.com/cms/asset/f85f5018-3b8f-436f-b05e-3b7c10fcd584/gr1.jpg)
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial - The Lancet Infectious
![Antiviral activity assessment of remdesivir against 10 current and former SARS-CoV-2 variant clinical isolates Antiviral activity assessment of remdesivir against 10 current and former SARS-CoV-2 variant clinical isolates](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_704551_16449408235975119.jpg)